|
 Taming the Epidemic: Strategies to Reduce Morbidity and Mortality in COPD
CME Credits are FREE click here for details.
|
 |
|
|
|
|
|
Recognizing and Destigmatizing COPD in the 21st Century
A clinical discussion with
A clinical discussion with E. Rand Sutherland, MD, MPH, FCCP; Hosted by Leo C. Rotello, MD, FCCP, FCCM, FACP
In this interview, Dr. Sutherland will discuss the importance of destigmatizing COPD and accurately diagnosing patients of all ages. He will also review the value of early diagnosis and intervention with aggressive therapies at all stages of the disease.
[View Course]
[Earn Certificate]
|
 |
The GOLD Standard for Managing COPD in Your Practice
Reviewed by
Timothy Op’t Holt, EdD, RRT, AE-C, FAARC and E. Rand Sutherland, MD, MPH, FCCP
This course will provide an evidence-based guide to this process as well as a &qt;tool kit&qt; for the integration of the GOLD guidelines into practice.
[View Course]
[Earn Certificate]
|
|
|
|
|
|
|
|
| Instant Replay |
|
 Meet the Expert: Special Topics in COPD
With Thomas Petty, MD
Symptoms of depression are stronger predictors of poor quality of life than are objective measures of pulmonary function. This dynamic Web Workshop will offer you insight into identifying symptoms of depression in your COPD patients.
[View Instant Replay] |
|
Target Audience
This CME activity is designed for physicians specializing in allergy, asthma, and immunology, as well as other healthcare providers who are involved in the diagnosis and treatment of patients with COPD.
|
Continuing Medical Education for Physicians
Accreditation Statement
MEBN is
accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
CME Credits
MEBN designates this
educational activity for a maximum of two (2) AMA PRA
Category I Credit(s)™. Physicians should only claim credit commensurate with
the extent of their participation in the activity.
FDA Disclosure Statement
The contents of some CME activities may contain discussions of
non-approved or off-label uses of some of the agents mentioned. Please consult
the prescribing information for full disclosure of approved
uses. |
|
|
Accreditation Period
Original release date: February 20, 2005
Review date: February 20, 2007
Expiration date: February 20, 2008
|
|
|
